Self-assembled micelles of N-phthaloylchitosan-g-poly (N-vinylcaprolactam) for temperature-triggered non-steroidal anti-inflammatory drug delivery
Source abstract
Abstract
A thermo-sensitive biocompatible amphiphilic material, N-phthaloylchitosan-g-poly(N-vinylcaprolactam) which could self-assemble into spherical micelles with good stability in aqueous medium, was synthesized. Meloxicam (MLX), a strongly hydrophobic pain killer for ankylosing spondylitis, was encapsulated into the hydrophobic cores of the micelles successfully as a model drug. The micelles showed excellent stability after MLX loading. Furthermore, the prepared micelles presented obvious thermo-sensitivity with lower critical solution temperature around 32 °C, where the MLX release rate reduced obviously when the temperature increased above it. This drug delivery system could achieve long time drug release under body temperature. The obtained biosurfactant should be an ideal candidate for applications in the development of long-lasting drug delivery systems.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Advanced Drug Delivery Systems · Nanoparticle-Based Drug Delivery · Anesthesia and Pain Management
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (38)
Show source-provided references
1. Braun J, Bollow M, Remlinger G, Eggens U, Rudwaleit M, Distler A, Sieper J (1998) Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum 41:58–6710.1002/1529-0131(199801)41:1<58::AID-ART8>3.0.CO;2-G ↗
2. Dougados M, Gueguen A, Nakache JP, Velicitat P, Veys EM, Zeidler H, Calin A (1999) Ankylosing spondylitis: what is the optimum duration of a clinical study? A one year versus a 6 weeks non-steroidal anti-inflammatory drug trial. Rheumatology 38:235–24410.1093/rheumatology/38.3.235 ↗
3. Braun J, Brandt J, Listing J, Zink A, Alten R, Golder W et al (2002) Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet 359:1187–119310.1016/S0140-6736(02)08215-6 ↗
4. Rosario-Meléndez R, Yu W, Uhrich KE (2013) Biodegradable polyesters containing ibuprofen and naproxen as pendant groups. Biomacromolecules 14:3542–354810.1021/bm400889a ↗
5. Luger P, Daneck K, Engel W, Trummlitz G, Wagner K (1996) Structure and physicochemical properties of meloxicam, a new NSAID. Eur J Pharm Sci 4:175–18710.1016/0928-0987(95)00046-1 ↗
6. Dougados M, Paternotte S, Braun J, Burgos-Vargas R, Maksymowych WP, Sieper J, van der Heijde D (2011) ASAS recommendations for collecting, analysing and reporting NSAID intake in clinical trials/epidemiological studies in axial spondyloarthritis. Ann Rheum Dis 70:249–25110.1136/ard.2010.133488 ↗
7. De Souza R, Zahedi P, Allen CJ, Piquette-Miller M (2009) Biocompatibility of injectable chitosan-phospholipid implant systems. Biomaterials 30:3818–382410.1016/j.biomaterials.2009.04.003 ↗
8. Shi W, Nie D, Jin G, Chen W, Xia L, Wu X et al (2012) BDNF blended chitosan scaffolds for human umbilical cord MSC transplants in traumatic brain injury therapy. Biomaterials 33:3119–312610.1016/j.biomaterials.2012.01.009 ↗
9. Gautam S, Chou CF, Dinda AK et al (2014) Fabrication and characterization of PCL/gelatin/chitosan ternary nanofibrous composite scaffold for tissue engineering applications. J Mater Sci 49:1076–1089. doi: 10.1016/j.msec.2012.12.01510.1007/s10853-013-7785-8 ↗
10. Zang S, Dong G, Peng B, Xu J, Ma Z, Wang X et al (2014) A comparison of physicochemical properties of sterilized chitosan hydrogel and its applicability in a canine model of periodontal regeneration. Carbohydr Polym 113:240–24810.1016/j.carbpol.2014.07.018 ↗
11. Sudheesh Kumar PT, Lakshmanan VK, Anilkumar TV, Ramya C, Reshmi P, Unnikrishnan AG et al (2012) Flexible and microporous chitosan hydrogel/nano ZnO composite bandages for wound dressing: in vitro and in vivo evaluation. ACS Appl Mater Interfaces 4:2618–262910.1021/am300292v ↗
12. Tran NQ, Joung YK, Lih E, Park KD (2011) In situ forming and rutin-releasing chitosan hydrogels as injectable dressings for dermal wound healing. Biomacromolecules 12:2872–288010.1021/bm200326g ↗
13. Jayakumar R, Menon D, Manzoor K, Nair SV, Tamura H (2010) Biomedical applications of chitin and chitosan based nanomaterials—a short review. Carbohydr Polym 82:227–23210.1016/j.carbpol.2010.04.074 ↗
14. Upadhyaya L, Singh J, Agarwal V, Tewari RP (2013) Biomedical applications of carboxymethyl chitosans. Carbohydr Polym 91:452–46610.1016/j.carbpol.2012.07.076 ↗
15. Deng D, Qu L, Zhang J, Ma Y, Gu Y (2013) Quaternary Zn-Ag-In-Se quantum dots for biomedical optical imaging of RGD-modified micelles. ACS Appl Mater Interfaces 5:10858–1086510.1021/am403050s ↗
16. Kumar MR, Muzzarelli R, Muzzarelli C, Sashiwa H, Domb AJ (2004) Chitosan chemistry and pharmaceutical perspectives. Chem Rev 104:6017–608410.1021/cr030441b ↗
17. Cheng C, Xia D, Zhang X et al (2015) Biocompatible poly(N-isopropylacrylamide)-g-carboxymethyl chitosan hydrogels as carriers for sustained release of cisplatin. J Mater Sci 50:4914–4925. doi: 10.1007/s10853-015-9036-710.1007/s10853-015-9036-7 ↗
18. Wang H, Zhao P, Liang X, Gong X, Song T, Niu R, Chang J (2010) Folate-PEG coated cationic modified chitosan-cholesterol liposomes for tumor-targeted drug delivery. Biomaterials 31:4129–413810.1016/j.biomaterials.2010.01.089 ↗
19. Park K (2014) Controlled drug delivery systems: past forward and future back. J Control Release 190:3–810.1016/j.jconrel.2014.03.054 ↗
20. Ping Y, Liu CD, Tang GP, Li JS, Li J, Yang WT, Xu FJ (2010) Functionalization of chitosan via atom transfer radical polymerization for gene delivery. Adv Funct Mater 20:3106–311610.1002/adfm.201000177 ↗
21. Yang SJ, Lin FH, Tsai KC, Wei MF, Tsai HM, Wong JM, Shieh MJ (2010) Folic acid-conjugated chitosan nanoparticles enhanced protoporphyrin IX accumulation in colorectal cancer cells. Bioconjugate Chem 21:679–68910.1021/bc9004798 ↗
22. Samal SK, Dash M, Van Vlierberghe S, Kaplan DL, Chiellini E, Van Blitterswijk C et al (2012) Cationic polymers and their therapeutic potential. Chem Soc Rev 41:7147–719410.1039/c2cs35094g ↗
23. Carreira AS, Goncalves FAMM, Mendonca PV, Gil MH, Coelho JFJ (2010) Temperature and pH responsive polymers based on chitosan: applications and new graft copolymerization strategies based on living radical polymerization. Carbohydr Polym 80:618–63010.1016/j.carbpol.2009.12.047 ↗
24. Maeda Y, Nakamura T, Ikeda I (2002) Hydration and phase behavior of poly (N-vinylcaprolactam) and poly (N-vinylpyrrolidone) in water. Macromolecules 35:217–22210.1021/ma011034+ ↗
25. Laukkanen A, Valtola L, Winnik FM, Tenhu H (2004) Formation of colloidally stable phase separated poly (N-vinylcaprolactam) in water: a study by dynamic light scattering, microcalorimetry, and pressure perturbation calorimetry. Macromolecules 37:2268–227410.1021/ma035124l ↗
26. Lau AC, Wu C (1999) Thermally sensitive and biocompatible poly (N-vinylcaprolactam): synthesis and characterization of high molar mass linear chains. Macromolecules 32:581–58410.1021/ma980850n ↗
27. Prabaharan M, Grailer JJ, Steeber DA, Gong S (2008) Stimuli-Responsive chitosan-graft-poly (N-vinylcaprolactam) as a promising material for controlled hydrophobic drug delivery. Macromol Biosci 8:843–85110.1002/mabi.200800010 ↗
28. Hurtgen M, Liu J, Debuigne A, Jerome C, Detrembleur C (2012) Synthesis of thermo-responsive poly (N-vinylcaprolactam)-containing block copolymers by cobalt-mediated radical polymerization. J Polym Sci Polym Chem 50:400–40810.1002/pola.25045 ↗
29. Cavus S, Cakal E (2012) Synthesis and characterization of novel poly (N-vinylcaprolactam-co-itaconic acid) gels and analysis of pH and temperature Sensitivity. Ind Eng Chem Res 51:1218–122610.1021/ie2008746 ↗
30. Cakal E, Cavus S (2010) Novel poly (N-vinylcaprolactam-co-2-(diethylamino) ethyl methacrylate) gels: characterization and detailed Investigation on their stimuli-sensitive behaviors and network structure. Ind Eng Chem Res 49:11741–1175110.1021/ie1007097 ↗
31. Moshaverinia A, Roohpour N, Darr JA, Rehman IU (2009) Synthesis and characterization of a novel N-vinylcaprolactam-containing acrylic acid terpolymer for applications in glass-ionomer dental cements. Acta Biomater 5:2101–210810.1016/j.actbio.2009.02.015 ↗
32. Boyko V, Pich A, Lu Y, Richter S, Arndt KF, Adler HJP (2003) Thermo-sensitive poly (N-vinylcaprolactam-co-acetoacetoxyethyl methacrylate) microgels: 1-synthesis and characterization. Polymer 44:7821–782710.1016/j.polymer.2003.09.037 ↗
33. Kurita K, Ikeda H, Yoshida Y, Shimojoh M, Harata M (2002) Chemoselective protection of the amino groups of chitosan by controlled phthaloylation: facile preparation of a precursor useful for chemical modifications. Biomacromolecules 3:1–410.1021/bm0101163 ↗
34. Opanasopit P, Ngawhirunpat T, Chaidedgumjorn A, Rojanarata T, Apirakaramwong A, Phongying S et al (2006) Incorporation of camptothecin into N-phthaloyl chitosan-g-mPEG self-assembly micellar system. Eur J Pharm Biopharm 64:269–27610.1016/j.ejpb.2006.06.001 ↗
35. Wang Y, Liu Y, Liu Y, Wang Y, Wu J, Li R et al (2014) pH-sensitive pullulan-based nanoparticles for intracellular drug delivery. Polym Chem 5:423–43210.1039/C3PY00817G ↗
36. Kalyanasundaram K, Thomas JK (1977) Environmental effects on vibronic and intensities in pyrene monomer fluorescence and their application in studies of micellar systems. J Am Chem Soc 99:2039–204410.1021/ja00449a004 ↗
37. Oh KT, Lee ES (2008) Cancer-associated pH-responsive tetracopolymeric micelles composed of poly (ethylene glycol)-b-poly (l-histidine)-b-poly (L-lactic acid)-b-poly (ethylene glycol). Polym Adv Technol 19:1907–191310.1002/pat.1228 ↗
38. Liu P, Shi B, Yue C, Gao G, Li P, Yi H et al (2013) Dextran-based redox-responsive doxorubicin prodrug micelles for overcoming multidrug resistance. Polym Chem 4:5793–579910.1039/c3py00830d ↗